Search Results for " Ceritinib "
Ceritinib Related Products
Ceritinib is an antineoplastic kinase inhibitor used to treat anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) in patients with inadequate clinical response or intolerance to crizotinib It was developed by Novartis.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Ceritinib, pharmacopeial and non-pharmacopeial Ceritinib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Ceritinib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Ceritinib-related products are thoroughly characterized. Ceritinib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.